BridgeBio Pharma Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 8 trades in BridgeBio Pharma Inc (NASDAQ: BBIO) since 2025, across 1 member, worth an estimated $64.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). Democratic members are responsible for 100% of the trades and Republican members 0%. The most recent disclosure shown was filed April 2026, and Gilbert Cisneros has filed the most BBIO transactions among those shown, with 8. One notable disclosed move was a purchase by Gilbert Cisneros on August 8, 2025, up 40.6% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the BridgeBio Pharma Inc (BBIO) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
BridgeBio Pharma congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Gilbert Cisneros House | Apr 7, 2026 | Mar 19, 2026 | 19 days | BUY |  $1,001 - $15,000 | -6.55% | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 19, 2026 | 19 days | BUY | $1,001 - $15,000 | -6.55% | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 18, 2026 | 20 days | BUY | $1,001 - $15,000 | -6.62% | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 18, 2026 | 20 days | BUY | $1,001 - $15,000 | -6.62% | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 3, 2026 | 35 days | BUY | $1,001 - $15,000 | +1.47% | |
Gilbert Cisneros House | Apr 7, 2026 | Mar 3, 2026 | 35 days | BUY | $1,001 - $15,000 | +1.47% | |
Gilbert Cisneros House | Oct 10, 2025 | Sep 22, 2025 | 18 days | BUY | $1,001 - $15,000 | +27.05% | |
Gilbert Cisneros House | Sep 12, 2025 | Aug 8, 2025 | 35 days | BUY | $1,001 - $15,000 | +40.58% |
BridgeBio Pharma (BBIO) congressional trading FAQ
Can members of Congress legally trade BridgeBio Pharma (BBIO) stock?
Yes. Members of Congress are permitted to trade individual stocks, including BridgeBio Pharma (BBIO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional BridgeBio Pharma (BBIO) trades public?
Yes. Every congressional trade in BridgeBio Pharma (BBIO) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded BridgeBio Pharma (BBIO)?
Members of Congress have disclosed 8 trades in BridgeBio Pharma (BBIO) worth $64.00K across 1 members, according to public STOCK Act filings.
Which members of Congress have traded BridgeBio Pharma (BBIO)?
Recent and active filers of BridgeBio Pharma (BBIO) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade BridgeBio Pharma (BBIO) more?
Across disclosed BridgeBio Pharma (BBIO) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).
What is the most recent congressional BridgeBio Pharma (BBIO) trade?
The most recent disclosed BridgeBio Pharma (BBIO) trade was a purchase by Gilbert Cisneros, filed Apr 6, 2026.
Browse all stocks Congress tradesCongressional trading overviewBridgeBio Pharma (BBIO) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.